Please assess the completion status of the following clinical trial:

Trial Title: Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient hospitalized for a coronary artery bypass surgery~* Not urgent surgery~* Left ventricular ejection fraction (LVEF)\> 40 %~* 18 years and older~* patient who have sign the informed consent form~* Affiliation to the French Social Security.~Exclusion Criteria:~* Beating heart surgery with or without Cardiopulmonary Bypass~* Patient receiving another surgical gesture combined to the CABG~* Myocardial infarction or vascular cerebral attack less than 30 days~* Previous History of cardiac surgery;~* Renal failure (creatinine \> 200 µmol/l)~* Uncontrolled hypertension~* hyperkaliemy;~* hyperuricemy;~* Acute Coronary Syndrome~* Malignant tumor~* Unchecked infection~* Previous intravenous administration of Sandimmun ®;~* allergy to ciclosporin, ethyl alcohol, castor oil or nitrogen~* Pregnant Woman, parturient without contraception, or breast-feeding~* Age \< 18 years~* Patient who have not signed the form of consent;~* Patient Under guardianship or being the object of a legal protective measure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- cyclosporin (Type: ACTIVE_COMPARATOR): Intravenous cyclosporin injection.
- Pacebo (Type: PLACEBO_COMPARATOR): Intravenous injection of NaCl solution.

Based on this trial design, predict the completion outcome and termination type (if applicable).